维他费林A:一种具有抗炎作用的潜在选择性葡萄皮质皮质体受体调节剂
Yuan Liang1, Qiuyan Jiang1, Haoyang Zou1
1College of Food Science and Engineering, Jilin University, Changchun, 130062, China.
维他费林A与葡萄糖皮质体受体 (GR) 结合,但不激活它,显示出抗炎作用. 这表明Withaferin A是潜在的选择性GR调节器用于炎症治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 自然产品 化学 化学
背景情况:
- 葡萄糖皮质类药物是有效的抗炎药物,但会引起严重的副作用.
- 葡萄糖皮质体受体 (GR) 是葡萄糖皮质体作用的关键介质.
- 选择性GR调节器 (SEGRMs) 旨在保持治疗效益,同时减少副作用.
研究的目的:
- 研究Withaferin A作为一种潜在的选择性GR调节器.
- 通过GR调制评估Withaferin A的抗炎作用.
- 为了阐明Withaferin A和GR之间的分子相互作用.
主要方法:
- 光极化试验以确定与GR的结合亲和力.
- 核分离和双 luciferase 记者测试以评估 GR 转录活动.
- 分子对接和动力学模拟来分析连接体-受体相互作用.
- 测试ELISA测量细胞因子的产生和评估抗炎活性.
主要成果:
- 维他费林A与GR结合,其IC50为203.80±0.36微米.
- 维他费林A不激活GR介导的转录,但会降低GR相关蛋白质的表达.
- 分子对接和动力学模拟证实了Withaferin A和GR之间的稳定结合相互作用.
- 维他费林A显著抑制了促炎性细胞因子的产生.
结论:
- 维他费林A作为一种潜在的选择性GR调节剂,具有已证明的抗炎性质.
- 与传统的葡萄糖皮质类药物相比,Withaferin A可能提供一种治疗策略,副作用较少.
- 这些发现支持Withaferin A的发展,用于食补充剂和针对炎症的营养保健品.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
07:50Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
